chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the vaccine at 5:35pm. Our intern, gave it to her and was in the consultation  room for quite awhile  (7-10 minutes) before she consulted me.  said that the patient is sitting down in the room, but it having some throat itching. I then went into the room to help and talk with . I first asked her how she was feeling. She said "ok" but was having throat itching, but no other symptoms right now. I had the Epi-pen out and ready to administer if she were to have any other severe symptoms. We then talked extensively about her allergies and how she was very nervous to get the vaccine at all; she had put it off until the last minute and had done a lot of research with her doctor about which one to get so she could avoid 100% of her allergies. She saw that the J & J vaccine contained something of a yellow stain/dye, but upon further investigation, it was a plant derived oil and she was comfortable getting it. While we talked, I took  her blood pressure and kept monitoring for any other symptoms (fainting, lip swelling, tongue swelling, etc.). She never experienced any other symptoms besides a little bit of lightheadedness that went away.  Her blood pressure was elevated (170/110, 156/100) but was coming down each time. She stated that her blood pressure at home and in the office is usually 128/86 or around there.  was very anxious at first, but calmed down immensely after sitting and talking with her for over an hour. We gave her water and she purchased a box of diphenhydramine 25mg and took two of them around 5:50pm. By 6:30pm she was much more calm and was comfortable leaving and meeting her husband who was right down the street. I told her to come back or call me if she needed anything else or had any other questions.
Arm became sore and started itching the next morning. Then became hard, red, warm and swelled.
Expired vaccine given last 30 Sept; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given last 30 Sept) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given last 30 Sept). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given last 30 Sept) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Oct-2021: Added drug start date and updated event verbatim.
My arm started swelling and itchy since Feb 7 around 4 AM. I'm experiencing pain in my arm. I took Benadryl and Tylenol.
Chills, high temp, dizziness, weakness, headache, nausea, loss of appetite, sore Rt nostril, Rt arm inflamed, hard/red and sore, lower B/P, coughing. TYLENOL, TORADOL, sodium chloride. Chest x-ray, urinalysis, blood work. ZOFRAN, VANCOCIN.
Child presented to clinic on 5/15/2001 at 08:30 AM, with multiple erythematous, papular, pruritic lesions on body; which developed approx. 36 + hours, post vax, Hep-B (primary dose). Child seen by PMD and given RX for Atarax.
Nausea, chest pain, headache, malaise, body aches starting 48 hours after first dose. Worsening with 2nd dose. Tightness in chest lasted for 3 days.
COLD SORES IN NASAL CAVITY; PAINFUL IN NASAL CAVITY; BUTTOCK CHEEK BURNING SENSATION; BUTTOCK CHEEK ITCHING SENSATION; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's past medical history included cold sores in nose.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, once a total administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-MAR-2021, the subject experienced buttock cheek burning sensation. On 05-MAR-2021, the subject experienced buttock cheek itching sensation. On 10-MAR-2021, the subject experienced cold sores in nasal cavity. On 10-MAR-2021, the subject experienced painful in nasal cavity. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from buttock cheek burning sensation, and buttock cheek itching sensation on 05-MAR-2021, and had not recovered from cold sores in nasal cavity, and painful in nasal cavity. This report was non-serious.
HEADACHE, EXTREME FATIGUE, SORE THROAT, RUNNY NOSE, CHEST PAIN, COUGHING, CONGESTION, WHEEZING..
Patient was fine in the office and then upon exiting the facility passed out while getting out the door to the car. Patient was helped by another nurse from another office and then brought back to our office via wheelchair where he was examined and placed on the table with feet up . Had many facial abrasions. was given juice and some cookies and crackers . Was given cold wash cloth for face. B/P was initially 70/60 . Continued to monitor until about 4:15 pm at which time he was up and sitting and then was able to walk to the door without dizziness or nausea. He was then place in wheelchair and brought out to the car . He walked into the car with minimal assist and said he felt fine.
Most painful shot ever gotten, walked home afterwards arrived by noon and started shaking all over chills. Put blanket on, could not lift glass of water, chills persisted for 5 hours. During kept drinking water and ate something. Probably had fever over night because woke up wet with perspiration. Called doctor on 9/15. On 9/15 felt weak could hardly walk, wiped out/tired, slept for about 12 hours. Today still feels weak. Took no medications.
Headache; Soreness in left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 98 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 09:00 (Lot number: EN6202) at the age of 98 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "diagnosed allergies" (unspecified if ongoing); "compromised immune status" (unspecified if ongoing); "respiratory illness" (unspecified if ongoing); "genetic / chromosomal abnormalities" (unspecified if ongoing); "endocrine abnormalities" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "obesity" (unspecified if ongoing); "Kidney disease" (unspecified if ongoing); "Atrial Fibrillation" (unspecified if ongoing); "Barrett's disease" (unspecified if ongoing); "height, he stated he has shrunk some" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 04Mar2021, outcome "unknown", described as "Soreness in left arm"; HEADACHE (non-serious) with onset 06Mar2021, outcome "not recovered", described as "Headache".  Additional information: Patient did not receive additional vaccines on same date of the Pfizer Suspect. Patient had no history of previous immunization with Pfizer vaccine as suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had first vaccine 2 1/2 weeks ago. A day or two after, he started to get a headache and it continued every day for 2 weeks. It stopped and he was ok for a few days and yesterday they came back. Yesterday and today, he still has it. He would like to know how long might this continue and will it affect in any way as he was getting the second shot in 3 days. Patient also reported soreness in left arm in the afternoon on the day of vaccination. Events did not result to urgent care or physician office visit.   No follow-up attempts are possible. No further information is expected.
Jaw stiffness was noticed when waiting during the 15 minute period but did not think it was related. However the stiffness has continued and gotten worse. No know injury to area. It is not impacting my ability to talk, eat, drink.
TINGLING IN THE FINGERS; This spontaneous report received from a pharmacist concerned a 53 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced tingling in the fingers. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in the fingers. This report was non-serious.
Information has been received from a nurse who reported that her niece's whole cheerleading squad experienced stomach cramps and/or pelvic pain after receiving the first dose of GARDASIL. No further information is available.
2nd dose has not been administered yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old female patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose of Twinrix standard schedule on 29-MAR-2023).   On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: 2nd dose has not been administered yet). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-JUL-2023 The reporter asked how to proceed. The vaccine administration facility was the same as primary reporter. Reporter wishes to remain anonymous and did not consent to follow up. Till the time of reporting the did not receive the 2nd dose of Twinrix, which led to incomplete course of vaccination.
experiencing sharp pain in the lower abdomen.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 53 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN (non-serious), outcome "unknown", described as "experiencing sharp pain in the lower abdomen.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Myalgia, Arthralgia, Fever,  heaviness in legs, tinnitus Narrative:
Awoke on the following morning with bad headache and generalized muscle pain and weakness, difficulty lifting feet, walking in a shuffle, stairs difficult.
Received his primary smallpox vaccine in his left arm (3 jabs). Approximately 2-3 days after receipt of smallpox vaccine, SM woke up around 2 a.m. and went to the Emergency Room because he was having difficulty breathing. In addition to breathing difficulties, he also experienced chest pain. The chest pain described as substernal, sharp pain that was worse with deep breaths and its intensity was rated as 8/10 using pain scale. Pain was accompanied by an increased heart rate and sensation of heart pounding harder than normal. Pain decreased with sitting straight up. Placed on oxygen and placed on monitor, pain resolved without treatment within 60 minutes of arriving at ER. No lab work or diagnostics were completed. He did not recall a specific diagnosis prior to discharge, but he was instructed to return if his symptoms returned. Within 7 days following of vaccine receipt, SM was on a plane, Upon arrival in country, he felt feverish and his hands were shaky. SM also experienced generalized body aches, fatigue and a fever which was 100deg in the local clinic. These symptoms completely resolved within 10 days. Within hours of arrival in " country", SM had a recurrence of chest pain. He did not experience associated problems breathing, but was told that he was ashen and was "not looking good". He was not able to seek medical evaluation or treatment at that time. His chest pain resolved after 24 hours of constant pain (6-7/10). He noted chest pain improved when sitting up, but after 20 minutes, the chest pain felt with living down. Chest pain was made worse with deep breaths. SM does not recall all of details ("kind of out of it"), but denies palpitations, coughing or swelling of feet and ankles. Around post-vaccine day 7, SM noted a "rash" on his left upper arm - "looked like second degree sunburn." He noted increased redness and warmth about the size of an orange which surrounded his smallpox vaccine site and extended up to his left shoulder. The redness was "blotchy" and there was streaking noted on the back of the arm. The majority of his left upper arm was edematous. He could feel tender, swollen lymph nodes under his left axilla and also noted some swollen glands in his neck. The area was tender to touch and the intensity of tenderness/pain is rated as 6-7/10 on pain scale of 0 (=no pain) to 10 (=worst pain ever experienced). After his back pack strap hit his vaccine site bandage and rubbed the site, SM sought evaluation by the local medics. They monitored the site daily and delineating erythema with markers. No lab test or site cultures were obtained. SM received a course of oral antibiotics in addition to his doxycycline. The site began to improve by post-vaccination day 9 or 10 and th local reaction completely resolved by post-vaccination day 16. The scab fell off about 2 weeks later.
The pt developed arthritis in September of 1997. The pt was in a testing group for a vaccine for Lyme Disease.
Pt presented to clinic for 11 y/o well child exam. When 3rd HPV dose offered, Mom stated 2nd dose of HPV on 8/5/14 caused swollen eyes and choking sensation which prompted an ER visit. Mom was advised may be caused by HPV vaccine and to decline further doses.
Starting on the 28th I developed a rash on my chest. It was red bumps and covered the upper part of my chest. The red slowly went down to a duel red but the bumps are still there. The rash is also itchy . The itchiness seems to come and go in intensity but is still there.
Patient has not received her 2nd dose of the Moderna vaccine almost 5 months later; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd dose of the Moderna vaccine almost 5 months later) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd dose of the Moderna vaccine almost 5 months later). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd dose of the Moderna vaccine almost 5 months later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication information was not provided. Concomitant medication information was not provided.   This case was linked to MOD-2021-051942 (Patient Link).
monovalent booster given the day after the EUA was rescinded as had not pulled from use at that time/was not aware of need to stop giving; no actual adverse reaction noted in patient
8 days after vaccine,  first noticed itch at location.  Looked at it and was bright red and warm (about 3 inches wide by 2 inches deep) at site of injection. No other symptoms.  As of 4/7/21 still itches, but faded to a light pink.   (From what I understand "Covid Arm")
This spontaneous report as received from registered nurse, via a company representative referring to a 16 year old female patient. The patient's concurrent conditions included migraines and "unstable home situation". Her pertinent medical history was not mentioned. On 23-AUG-2017, the patient was vaccinated with a second dose GARDASIL 9 lot # N004799, 0.5 ml, intramuscular in the left deltoid for prophylaxis. She was also co-administrated medroxyprogesterone acetate (DEPO PROVERA). On 09-SEP-2017, the patient was seen at the Emergency Room for "needle-like" feelings in various parts of her body, and the patient reported that this feeling would "normally go away in 30 minutes" but this time the "needle-like feeling lasted for more than 2 hours in her left arm". On 18-SEP-2017, patient's mother called the physician's office to report that her daughter experienced weakness and numbness in both arms. The patient was seen by an unspecified physician for migraines. The patient received her first dose of GARDASIL 9 on 06-FEB-2017 without any adverse effects. The outcome of the events was not mentioned. The relatedness between vaccination with GARDASIL 9 and the events was unknown.
Roughly 2-3 days after vaccination, I started to have plugged ears, ear pain, vertigo, and tinnitus. These symptoms have diminished almost a month since, but the tinnitus has persisted, with occasional general ear discomfort.
Pt recvd DT 10NOV91 & noted lump about 4-5 days later & it persisted-intermittently painflu & sometimes it would go down; became worse-returned to ER 20FEB92 & lump was drained 10-15cc puss) tx Keflex;
Patient is an 84-year-old female with recent cellulitis, who presented from home with reports of low blood pressure and mental status changes. Initially, there was concern over persistent infection, but her urinalysis and other blood work were not consistent with persistent infection.  She remained afebrile and cultures were negative through her course.  We kept off antibiotics.  She did have followup with Dr.s team.  She did have acute kidney injury with creatinine up to 1.8, likely due to the hypotension.  Her ACE inhibitor was discontinued and we will keep her off this indefinitely now.  She received some hypotonic saline for hydration, actually had D5 half-normal.  Sodium fell down to 126.  Did resume her Lasix thereafter and sodium was trending up to 128.  This along with fluid restriction.  She had some persistent delirium at night, sometimes calling her family and being more confused, but was oriented during the day and not combative.  She has severe debility and degenerative arthritis, is able to stand, but her transfers are extremely slow and difficult.  She was felt to be a better candidate for extended care facility placement in the short-term.  Her creatinine was 0.9 at the time of discharge and sodium 128.  Hemoglobin was 11.2 and white count was 9.3.  Plan to discharge to nursing care facility hopefully later today.  Follow up in the office 1 week after discharge from there.
Patient has high blood pressure because of the hives; Patient broke up in bad hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Patient broke up in bad hives) and HYPERTENSION (Patient has high blood pressure because of the hives) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 06-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced URTICARIA (Patient broke up in bad hives). On an unknown date, the patient experienced HYPERTENSION (Patient has high blood pressure because of the hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency and PEPSIN at an unspecified dose and frequency. At the time of the report, URTICARIA (Patient broke up in bad hives) and HYPERTENSION (Patient has high blood pressure because of the hives) outcome was unknown.            concomitant medication included levothyroxine used for thyroids
Patient received second dose of Pfizer and after about 5 minutes patient started to get very lightheaded/dizzy.  She was helped to recliner chair where patient did pass out.  BP was checked and was 52/30, pulse 79.  She was visibly sweaty.  Patient was provided O2 and ice pack to help cool her down.  Patient was initially not able to answer questions but after a couple minutes was more aware.  Security arrived to assist as well as EMT .  Repeat bp readings were 97/48 after 10 minutes and then 103/76 after 20.  Patient did not eat for 16 hours prior and feels this contributed to her reaction.  EMT personnel did check patient out and patient declined transport to local ER.    Patient left 45 minutes after vaccination.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information was reported.  The date of placed in refrigerator was on 04-NOV-2021 and vaccine did not undergone any temperature excursion.  No other adverse events were reported for patient.  No Treatment information was reported.
Approximately 13 hours after receiving the vaccination, I started to experience a bit of confusion and then uncontrollable  chills for about a half hour. I then started to experience a low grade fever. After sleeping through the night I woke up with a strong headache and nausea and continuation of the fever. Symptoms continued for the rest of the day including exhaustion. The symptoms eventually subsided in the late afternoon.
Moderna covid-19 vaccine EUA Headache, tiredness, chills, malaise. Side effects lasted about 24 hours. Mild tenderness  at site of injection, lasted 2-3 days
Pt received your first dose of Moderna and approx 3 hours later, individual started to experience pruritic, burning, hives on fingers, head, stomach, and lower legs.  Pt describes it as if he was "stung by a 1000 fire ants."  2 hours later, edema started hands past the wrists (up to 3x their normal size).  That night, pt experienced difficulty breathing, interruption in breathing.  Pt describes it as sleep apnea.  Next morning, pt went to the ED for evaluation, and diagnosed symptoms as allergic reaction to the Moderna vaccine.    These symptoms have recurred every month, symptoms hands and wrist pt notices blotchy discoloration, pruritic hives on his head, hands, ankles, and midsection.  Hives last for approximately 1 week and then dissipate.  Of the 7 days the pt experiences the hives, 2 out of those days, pt notes sleep apnea.